Response to comment on 'occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems' (Environmental Science and Technology (2009) 43, DOI: 10.1021/es9027524);Response to comment on "occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems"

Environmental Science and Technology

Volumn 43, Issue 22, 2009, Pages 8699-8700

  Post, Gloria B ^a   Cooper, Keith R ^b   Louis, Judith B ^a   Lippincott, R Lee ^a  

^a NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTION   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; PERFLUOROOCTANOIC ACID;

ACUTE HEART INFARCTION; ANEURYSM; ATHEROSCLEROSIS; BLADDER CANCER; CANCER RISK; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; HUMAN; KIDNEY CANCER; LETTER; MORTALITY; NONHUMAN; RISK ASSESSMENT; UNITED STATES; WATER CONTAMINATION; WATER SUPPLY;

EID: 72249097690     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es903038p     Document Type: Erratum

References (10)

1. Post, G. B.; Louis, J. B.; Cooper, K. R.; Boros-Russo, B. J.; Lippincott, R. L. Occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems. Environ. Sci. Technol. 2009, 43 (12), 4547-4554.
2. Tardiff, R. G. Comment on "Occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems". Environ. Sci. Technol. 2009, 43, DOI:10.1021/es902326f.
3. Tardiff, R. G.; Carson, M. L.; Sweeney, L. M.; Kirman, C. R.; Tan, Y.-M.; Andersen, M.; Bevan, C.; Gargas, M. L. Derivation of a Drinking Water Equivalent Level (DWEL) related to the Maximum Contaminant Level Goal for PFOA, a persistent water soluble compound. Food Chem. Toxicol. 2009; DOI:10.1016/j.fct.2009.07.016.
4. Clewell, H. J. Application of pharmacokinetic modeling to estimate PFOA exposure associated with measured blood concentrations in human populations. Powerpoint presentation at Society for Risk Analysis Annual Meeting; 2006.
5. Emmett, E. A.; Shofer, F. S.; Zhang, H.; Freeman, D.; Desai, C.; Shaw, L. M. Community exposure to perfluorooctanoate: Relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 2006, 48, 759-770. (Pubitemid 44221830)
6. USEPA. Estimated Per Capita Water Ingestion and Body Weight in the US; EPA-822-R-00-001; Washington, DC, 2004.
7. Harada, K.; Inoue, K.; Morikawa, A.; Yoshinaga, T.; Saito, N.; Koizumi, A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ. Res. 2005, 99, 253-261. (Pubitemid 41382452)
8. Rosen, M. B.; Lau, C.; Corton, J. C. Does Exposure to Perfluoroalkyl Acids Present a Risk to Human Health? Toxicol. Sci. 2009, 111, 1-3.
9. USEPA. Draft Risk Assessment of the Potential Human Health Effects Associated with Exposure to PFOA and Its Salts; Washington, DC, January 4, 2005.
10. USEPA. SAB Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts; Washington, DC, May 30, 2006.